LUX Infusion

05/19/2026

🎗️ American Stroke Month 🎗️
May is American Stroke Month, making it a vital time to emphasize the updated 2026 AHA/ASA stroke guidelines. We encourage our clinical partners to keep the BE FAST dialogue at the center of patient education. Collectively reinforcing the signs of:

• Balance Loss
• Eye (vision) changes

• Face drooping
• Arm weakness
• Speech difficulty
• Time to call 911

…ensures that the window of opportunity for advanced 2026 interventions is as wide as possible.

Together, we can turn “awareness” into “action.”

https://hubs.la/Q04gP4fR0

05/14/2026

𝗪𝗲’𝗿𝗲 𝗲𝘅𝗰𝗶𝘁𝗲𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗮𝘁 𝗟𝗨𝗫 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗶𝗻 𝗚𝗮𝗹𝗹𝗮𝘁𝗶𝗻 𝗵𝗮𝘀 𝗺𝗼𝘃𝗲𝗱 𝘁𝗼 𝗮 𝗻𝗲𝘄 𝗹𝗼𝗰𝗮𝘁𝗶𝗼𝗻!

As we continue to grow and invest in the patient experience, this new space will allow us to better serve patients throughout the region with high-touch, clinician-led infusion care in a comfortable and accessible setting.

Whether you’re a referring physician or a patient seeking infusion therapy, our team is ready to serve.

𝗩𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁:
214 Baber Park Drive West,
Suite 130
Gallatin, Tennessee 37066

𝗣𝗵𝗼𝗻𝗲: (615) 623-4456
𝗙𝗮𝘅: (844) 461-3244

𝗛𝗼𝘂𝗿𝘀 𝗼𝗳 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻:
Monday – Friday
9:00 am – 4:00 pm

05/08/2026

This National Nurses Week, we recognize the nurses who bring clarity to moments that don’t always feel clear.

The ones coordinating care behind the scenes.
Navigating complexity in real time.
Showing up for patients, not just clinically but person-to-person.

At LUX Infusion, we see that impact every day. We’re proud to work alongside an incredible network of nurses, both within our team and across the providers and partners we support.

𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗮𝗻𝗱 𝘀𝘁𝗲𝗮𝗱𝘆 𝗽𝗿𝗲𝘀𝗲𝗻𝗰𝗲 𝘆𝗼𝘂 𝗯𝗿𝗶𝗻𝗴 𝘁𝗼 𝗲𝘃𝗲𝗿𝘆 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲.

05/07/2026

We are proud to announce that our newest LUX Infusion location in Horseheads is officially open!

We’ve always believed that high-science infusion therapy should be accessible, so we’re working hard to grow into new areas that will allow more patients to experience high-touch, clinician-led care. By opening our Horseheads location, we’re bringing that standard of care closer to home for our patients in the Southern Tier.

Whether you’re a referring physician or a patient seeking in-center or home-based infusion therapy, our team is ready to serve.

Visit us at: 2977 Westinghouse Rd, Horseheads, NY 14845
Referrals & Appointments: 585-568-1522
Fax: 585-423-9488

04/29/2026

We are heading to the UNOS Transplant Management Forum, the premier gathering for transplant professionals focused on improving outcomes, advancing care, and connecting across the field.

𝐕𝐢𝐬𝐢𝐭 𝐋𝐔𝐗 𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧, 𝐟𝐨𝐫𝐦𝐞𝐫𝐥𝐲 𝐁𝐢𝐨𝐌𝐚𝐭𝐫𝐢𝐱 𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲, 𝐚𝐭 𝐁𝐨𝐨𝐭𝐡 𝟏𝟎𝟒.

While our look has changed, our focus remains the same. We deliver clinical excellence in a compassionate, patient centered environment you can trust. This is not just a new name. It is a new standard for transplant infusion care.

We look forward to seeing you in the light.

04/27/2026

𝗔 𝗡𝗲𝘄 𝗦𝘁𝗮𝗻𝗱𝗮𝗿𝗱 𝗳𝗼𝗿 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗖𝗹𝗮𝗿𝗶𝘁𝘆 💡

Our recent rebrand to LUX Infusion reflects a purposeful evolution in how we communicate our clinical standards.

We understand that for a provider, the “infusion gap”—the space between writing a prescription and a patient receiving their first dose—can often be a dark spot filled with administrative hurdles and logistical complexity. Here’s how we’re providing the light:

• 𝗔 𝟰-𝗵𝗼𝘂𝗿 𝘁𝘂𝗿𝗻𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗶𝗺𝗲 𝗳𝗿𝗼𝗺 𝗿𝗲𝗳𝗲𝗿𝗿𝗮𝗹 𝘁𝗼 𝘄𝗲𝗹𝗰𝗼𝗺𝗲 𝗰𝗮𝗹𝗹 and a dedicated nurse benefits and appeals team to move patients forward.

• 𝗔 𝘁𝗶𝗴𝗵𝘁 𝗰𝗼𝗺𝗺𝘂𝗻𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗹𝗼𝗼𝗽 between LUX Infusion and your practice, so you always have data on how patients are tolerating therapy and progressing toward outcomes.

• 𝗔𝗻 𝗲𝗹𝗲𝘃𝗮𝘁𝗲𝗱 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 that prioritizes patients, with at-home or at-center infusion options, flexible scheduling, and personalized attention, all designed for comfort.

04/22/2026

🚨 𝗣𝗵𝗮𝘀𝗲 𝟯 𝗨𝗟𝗧𝗜𝗠𝗔𝗧𝗘 𝗜 & 𝗜𝗜 𝗗𝗮𝘁𝗮 𝗨𝗽𝗱𝗮𝘁𝗲 🚨

New data published last month in Neurology and Therapy (March 9) reinforces why we advocate for high-efficacy intervention early in the disease course for Relapsing MS (RMS).

A pooled analysis of the Phase 3 ULTIMATE I & II studies for BRIUMVI (ublituximab-xiiy) demonstrated a 95.6% reduction in Gd+ T1 lesions over 96 weeks compared to standard oral therapies. Another observed benefit over teriflunomide was that BRIUMVI patients were nearly 5 times more likely to achieve NEDA-3 during weeks 24–96.

At LUX Infusion, we see the critical importance of optimizing therapy in challenging cases of RMS, so we work hard to remove the logistical, financial, and clinical barriers that might prevent patients from accessing early, high-efficacy treatment.

Link in the comments to learn more!

04/17/2026

𝗠𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝘁𝗵𝗲 𝗠𝗼𝗺𝗲𝗻𝘁𝘂𝗺 𝗶𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗖𝗮𝗿𝗲 🧠

The transition to LUX Infusion highlights our focus on the long-term journey of the patient. The FDA has accepted a Supplemental Biologics License Application (sBLA) for LEQEMBI® IQLIK™ (lecanemab-irmb) as a weekly subcutaneous (SC) starting dose, granting it priority review.

If approved, the implications are significant: this would allow providers to initiate SC therapy right from the start, rather than just during the maintenance phase (and would be the first anti-amyloid therapy to offer this). The FDA filing comes off the back of the Phase 3 Clarity AD study showing that a weekly 500mg SC dose achieves equivalent exposure and similar clinical/biomarker benefits to standard bi-weekly infusions.

We are closely watching the FDA action date set for May 24, because—whether care happens in our centers or through a transition to home-based dosing—we believe therapy should adapt to the patient, not the other way around.

Click the link in the comments to learn more!

04/13/2026

Catch the LUX Infusion Team This April!

We are thrilled to officially introduce LUX Infusion! While our look has evolved, our mission remains the same: providing elevated infusion care that combines clinician-led expertise with a patient-first experience.

To celebrate, we’re taking the new LUX Infusion brand on the road this April! Catch our team at these upcoming meetings:

𝗔𝗽𝗿𝗶𝗹 𝟭𝟱–𝟭𝟵: American Association of Immunologists (AAI) | Boston, MA
𝗔𝗽𝗿𝗶𝗹 𝟭𝟲–𝟭𝟵: Hemophilia Federation of America (HFA) | New Orleans, LA
𝗔𝗽𝗿𝗶𝗹 𝟭𝟴–𝟮𝟮: American Academy of Neurology (AAN) | Chicago, IL
𝗔𝗽𝗿𝗶𝗹 𝟭𝟴–𝟮𝟮: National Home Infusion Association (NHIA) | Aurora, CO
𝗔𝗽𝗿𝗶𝗹 𝟮𝟯–𝟮𝟰: Alaska Nurse Practitioner Spring Conference | Anchorage, AK
𝗔𝗽𝗿𝗶𝗹 𝟮𝟯–𝟮𝟰: NAMCP Spring Managed Care Forum | Orlando, FL
𝗔𝗽𝗿𝗶𝗹 𝟮𝟲–𝟯𝟬: Asembia | Las Vegas, NV
𝗔𝗽𝗿𝗶𝗹 𝟮𝟵–𝗠𝗮𝘆 𝟭: UNOS Transplant Management Forum | Atlanta, GA

Will you be at any of these events? We’d love to show you the new look and discuss how we can support your patients. Drop a comment below if we’ll see you there!

04/01/2026

𝗔 𝗕𝗿𝗶𝗴𝗵𝘁 𝗡𝗲𝘄 𝗖𝗵𝗮𝗽𝘁𝗲𝗿 𝗳𝗼𝗿 𝗟𝗨𝗫 𝗜𝗻𝗳𝘂𝘀𝗶𝗼𝗻
To our community: you may notice some exciting changes to our look!

Today, we are proud to share that the LUX Infusion name is officially becoming the standard for the entire BioMatrix national network.

Our logo and branding is evolving to reflect this unification, but our vision for infusion care remains the same—we are bringing the same clinician-led expertise and patient-first focus you’ve always trusted, now brought together under a single name.

Explore the new look at https://luxinfusion.com

(𝗔𝗻𝗱 𝘄𝗲 𝗽𝗿𝗼𝗺𝗶𝘀𝗲, 𝘁𝗵𝗶𝘀 𝗶𝘀 𝗻𝗼 𝗔𝗽𝗿𝗶𝗹 𝗙𝗼𝗼𝗹𝘀' 𝗗𝗮𝘆 𝗷𝗼𝗸𝗲!)

See infusion care in a new light LUX Infusion delivers infusion treatment with clarity, compassion, and expertise–so every step towards better health feels brighter. I'm a patient I'm a provider CARE OPTIONS Infusion treatment that meets you where you are LUX Infusion provides an elevated core ex...

10/29/2025

Meet Kim Black, the new Senior Territory Account Executive at LUX Infusion 🌿

With 20+ years of healthcare experience, Kim is passionate about connecting Alaskans to exceptional outpatient infusion care.

Learn more about Kim, her background & why LUX Infusion is proud to have her as part of our team.

👉 www.luxinfusion.com/blog/kim-black-joins-lux-infusion-as-senior-territory-account-executive